Novavax Stock Chart Fibonacci Analysis 090625Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 7.3/61.80%
Chart time frame:C
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress:A
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
E)
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.61 USD
−187.50 M USD
682.16 M USD
147.95 M
About Novavax, Inc.
Sector
Industry
CEO
John C.s Jacobs
Website
Headquarters
Gaithersburg
Founded
1987
ISIN
US6700024010
FIGI
BBG000NVSBL7
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Related stocks
LONG NVAX"Novavax is the dark horse of the pharma race – while the market watches Pfizer and Moderna, NVAX is quietly strengthening its position with an improved protein-based vaccine. The approval of their combined COVID and flu shot might be just the beginning. And here’s the kicker – in every bull run, sp
NVAX Update (Responding to Some Requests)I wrote this in response to a comment on a previous update, but I'm publishing this here because some others have requested an update as well.
Remember: I'm just some dude on the internet and I'm not a financial advisor. So please keep that in mind.
For me, personally, NVAX is a patience game. I
NVAX Potential Breakout!Potential Breakout in the next week for NVAX. Would not be surprised to see a move to around $10.60 in the next few days. If it can break the bigger wedge, a potential big upside to around $14-$15 range.
Besides this short term idea, the stock has even greater upside from a TA point of view if you
$NVAX - GAP FILL & BREAK OF TRANEDLINE NASDAQ:NVAX gaining momentum again along with other pharma's. Its interestingly filling the gap anf has i high possibility of retesting the high of the channel. I have a starter position and will be adding if it decides to test the trend line. A daily close below the trendline is my stop. Playing e
Shot At Vaccinating Gains!Novavax (NVAX) is demonstrating strong bullish momentum, with a gap forming around the $8.75 level. A breakout above the $14.60 monthly resistance would confirm continued strength, positioning the stock to target $23.71. This trade offers an excellent risk-to-reward ratio, with downside risk managed
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
NVAX6156110
Novavax, Inc. 4.625% 01-SEP-2031Yield to maturity
—
Maturity date
Sep 1, 2031
NVAX5729297
Novavax, Inc. 5.0% 15-DEC-2027Yield to maturity
—
Maturity date
Dec 15, 2027
See all NVAX bonds
Curated watchlists where NVAX is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Novavax, Inc. stocks are traded under the ticker NVAX.
We've gathered analysts' opinions on Novavax, Inc. future price: according to them, NVAX price has a max estimate of 25.00 USD and a min estimate of 6.00 USD. Watch NVAX chart and read a more detailed Novavax, Inc. stock forecast: see what analysts think of Novavax, Inc. and suggest that you do with its stocks.
NVAX reached its all-time high on Feb 8, 2022 with the price of 95.27 USD, and its all-time low was 3.73 USD and was reached on Feb 6, 2024. View more price dynamics on NVAX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Novavax, Inc. financials in yearly and quarterly reports right on TradingView.
Novavax, Inc. is going to release the next earnings report on Nov 5, 2025. Keep track of upcoming events with our Earnings Calendar.
NVAX earnings for the last quarter are 0.62 USD per share, whereas the estimation was 0.01 USD resulting in a 7.26 K% surprise. The estimated earnings for the next quarter are −0.49 USD per share. See more details about Novavax, Inc. earnings.
Novavax, Inc. revenue for the last quarter amounts to 239.24 M USD, despite the estimated figure of 152.61 M USD. In the next quarter, revenue is expected to reach 65.93 M USD.
NVAX net income for the last quarter is 106.51 M USD, while the quarter before that showed 518.65 M USD of net income which accounts for −79.46% change. Track more Novavax, Inc. financial stats to get the full picture.
No, NVAX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 27, 2025, the company has 952 employees. See our rating of the largest employees — is Novavax, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Novavax, Inc. EBITDA is 407.48 M USD, and current EBITDA margin is −26.90%. See more stats in Novavax, Inc. financial statements.
Like other stocks, NVAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Novavax, Inc. stock right from TradingView charts — choose your broker and connect to your account.